Last Updated: May 2, 2026

Profile for Chile Patent: 2016001609


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2016001609

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jan 2, 2035 Astrazeneca TAGRISSO osimertinib mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chile Drug Patent CL2016001609

Last updated: August 6, 2025


Introduction

Patent CL2016001609, granted in Chile, pertains to a pharmaceutical invention aimed at securing exclusive rights over specific compositions, formulations, or methods of treatment related to a particular drug or therapeutic use. Analyzing the patent's scope, claims, and its standing within the patent landscape offers critical insights for stakeholders including generic manufacturers, investors, and legal practitioners.


Patent Overview

Patent Number: CL2016001609
Grant Date: The specific date is unavailable herein but typically follows the application period.
Applicant/Patentee: (Details specific to the patent should be inserted here, if known.)
Jurisdiction: Chile (conferred under Chilean patent law, in accordance with the Union for theProtection of Industrial Property—UPOV—and relevant national legislation).

This patent appears to focus on a novel pharmaceutical composition or a specific formulation, involving therapeutic agents aimed at treating a defined medical condition.


Scope of the Patent

The scope of CL2016001609 is primarily delineated by its claims, which specify the legal breadth of the patent protection. In Chilean patent practice, the scope is anchored primarily in the wording of the claims, supported by the description and drawings.

1. Core Claim Characteristics:

  • The claims typically cover a specific chemical composition, such as a drug formulation comprising particular active ingredients, excipients, or delivery mechanisms.
  • Alternatively, claims may encompass a method of manufacturing or administering the pharmaceutical composition.

2. Patent Coverage Evaluation:

  • The patent encompasses the precise molecular structure or composition as claimed, preventing others from producing, using, or selling identical or equivalent formulations within Chile.
  • The scope extends as well to methods of treatment, which, if claimed, could restrict medical use unless explicitly permitted.

3. Limitations:

  • Chilean patent law highly emphasizes novelty, inventive step, and industrial applicability, meaning the scope is confined to inventions not previously disclosed, considered inventive, and practically applicable.

Claims Analysis

1. Independent Claims:

  • They define the broadest exclusive rights, usually covering the core innovative concept, such as a specific compound or treatment method.
  • For example, an independent claim might cover "a pharmaceutical composition comprising compound X in combination with excipient Y for treating condition Z."

2. Dependent Claims:

  • Narrower claims that specify particular embodiments, such as dosage forms, concentration ranges, or delivery methods.
  • These serve to reinforce and expand the scope around the independent claims.

3. Novelty and Inventive Step:

  • The claims must demonstrate novelty over prior art—existing patents, scientific publications, or known treatments—and exhibit an inventive step to warrant patentability.
  • Chilean patent examination involves assessing prior art references within the patent's filing date to ensure claims are non-obvious.

4. Limitations and Potential Challenges:

  • Overly broad claims risk invalidation if prior art anticipates or renders the invention obvious.
  • Patent applicants often draft multiple dependent claims to encompass various embodiments, thus strengthening their position against possible infringement or invalidation.

Patent Landscape in Chile and International Context

1. Chile's Pharmaceutical Patent Environment:
Chile adheres to the TRIPS agreement, requiring patentability standards aligned with international norms. Its patent office (INAPI) conducts substantive examination, especially for chemical and pharmaceutical inventions, often scrutinizing inventive step and prior art.

2. Patent Family and Related Patents:

  • The patent in question may be part of a broader patent family, including filings in other jurisdictions such as the US, Europe, or Latin America, which can influence its strength and enforceability.
  • A search into patent databases (e.g., WIPO PATENTSCOPE, EPO Espacenet) indicates whether this invention has equivalents or related patents abroad.

3. Competitive Landscape and Potential Infringement Risks:

  • Other patents for similar compounds or formulations, especially in the region, could pose infringement risks.
  • Patent thickets in specific therapeutic areas (e.g., oncology, infectious diseases) are common, requiring detailed freedom-to-operate analyses.

4. Patent Life and Maintenance:

  • In Chile, patents generally last 20 years from the filing date, subject to compliance with maintenance fees, which are vital for ongoing exclusivity.

Legal and Commercial Implications

  • For Innovators: The patent provides a period of market exclusivity, enabling recoupment of R&D investments.
  • For Generics: The scope defines the boundaries of permissible generic development. Thorough claim analysis aids in designing around strategies.
  • For Investors: Patent strength and landscape impact valuation, licensing opportunities, and partnership negotiations.

Conclusion and Recommendations

The scope of Chilean patent CL2016001609, primarily governed by its claims, appears focused on a specific pharmaceutical composition or method, with protections likely encompassing various embodiments associated with the declared inventive concept. Its position within the patent landscape requires evaluation against regional and global patent families, prior art, and potential competitors.

Stakeholders must:

  • Conduct comprehensive freedom-to-operate searches aligned with the patent's claims.
  • Monitor the patent's enforceability status, considering maintenance and legal challenges.
  • Explore licensing or partnership opportunities leveraging the patent's coverage.

Key Takeaways

  • The patent’s scope hinges on the precise language of its claims, necessitating detailed legal and technical interpretation to assess risks and opportunities.
  • Understanding the patent landscape in Chile and internationally is crucial for strategic planning, especially considering potential infringement or designing around the patent.
  • Robust claim drafting and comprehensive prior art searches are essential to uphold and defend patent rights.
  • Continuous monitoring of patent maintenance and legal status ensures sustained exclusivity and value realization.
  • Cross-jurisdictional patent filing and family analysis strengthen global patent protection strategies.

FAQs

  1. What is the primary focus of Chilean patent CL2016001609?
    The patent centers on a specific pharmaceutical composition or treatment method, as detailed in its claims, aimed at providing exclusive rights within Chile.

  2. How broad are the claims likely to be in this patent?
    The claims' breadth depends on how specifically the inventors defined the composition or method; broader claims offer more protection but face higher invalidation risks.

  3. Can this patent be challenged or invalidated in Chile?
    Yes, through legal procedures like opposition or nullity actions based on prior art, lack of novelty, or inventive step challenges.

  4. How does this patent fit within the global patent landscape?
    It may form part of a patent family; similar inventions might be protected in other jurisdictions, influencing licensing and enforcement strategies.

  5. What strategies should licensees or competitors adopt?
    They should carefully analyze the claims, assess infringement risks, consider designing around the patent, and monitor legal updates for potential challenges.


References

  1. INAPI Chilean Patent Database
  2. WIPO PATENTSCOPE
  3. European Patent Office (EPO) Espacenet
  4. TRIPS Agreement (WTO)
  5. Relevant Chilean patent laws and regulations

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.